Literature DB >> 17135693

Staging of primary malignancies of bone.

Robert K Heck1, Terrance D Peabody, Michael A Simon.   

Abstract

Staging of bone sarcomas is the process whereby patients are evaluated with regard to histology, as well as the local and distant extent, of disease. Bone sarcomas are staged based on grade, size, and the presence and location of metastases. The system is designed to help stratify patients according to known risk factors. Proper staging helps define the prognosis for patients and helps guide their treatment. Furthermore, staging allows meaningful comparisons to be done among groups of patients.

Entities:  

Mesh:

Year:  2006        PMID: 17135693     DOI: 10.3322/canjclin.56.6.366

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  19 in total

1.  Usefulness of increased 18F-FDG uptake for detecting local recurrence in patients with extremity osteosarcoma treated with surgical resection and endoprosthetic replacement.

Authors:  Kyoung Jin Chang; Chang-Bae Kong; Wan Hyeong Cho; Dae-Geun Jeon; Soo-Yong Lee; Ilhan Lim; Sang Moo Lim
Journal:  Skeletal Radiol       Date:  2014-11-29       Impact factor: 2.199

2.  Is bone scintigraphy necessary in the initial surgical staging of chondrosarcoma of bone?

Authors:  Hassan Douis; Steven L James; Robert J Grimer; Mark A Davies
Journal:  Skeletal Radiol       Date:  2011-09-03       Impact factor: 2.199

3.  ALDH Activity Correlates with Metastatic Potential in Primary Sarcomas of Bone.

Authors:  Nicholas Greco; Trevor Schott; Xiaodong Mu; Adam Rothenberg; Clifford Voigt; Richard L McGough; Mark Goodman; Johnny Huard; Kurt R Weiss
Journal:  J Cancer Ther       Date:  2014-03-31

4.  Tumor necrosis in osteosarcoma: inclusion of the point of greatest metabolic activity from F-18 FDG PET/CT in the histopathologic analysis.

Authors:  Colleen M Costelloe; A Kevin Raymond; Nancy E Fitzgerald; Osama R Mawlawi; Rodolfo F Nunez; John E Madewell; Robyn K Harrell; Roland L Bassett; Edith M Marom
Journal:  Skeletal Radiol       Date:  2009-09-17       Impact factor: 2.199

5.  D-dimer levels as a prognostic factor for determining oncological outcomes in musculoskeletal sarcoma.

Authors:  Takeshi Morii; Kazuo Mochizuki; Takashi Tajima; Shoichi Ichimura; Kazuhiko Satomi
Journal:  BMC Musculoskelet Disord       Date:  2011-11-01       Impact factor: 2.362

6.  Guidelines for histopathological specimen examination and diagnostic reporting of primary bone tumours.

Authors:  D Charles Mangham; Nicholas A Athanasou
Journal:  Clin Sarcoma Res       Date:  2011-07-25

7.  Staging investigations in chondrosarcoma: Is evaluation for skeletal metastases justified? Analysis from an epidemiological study at a tertiary cancer care center and review of literature.

Authors:  Ashish Gulia; Ajay Puri; Suman Byregowda
Journal:  South Asian J Cancer       Date:  2016 Jan-Mar

8.  EFFICACY OF THE ENNEKING STAGING SYSTEM IN RELATION TO TREATING BENIGN BONE TUMORS AND TUMOR-LIKE BONE LESIONS.

Authors:  José Marcos Nogueira Drumond
Journal:  Rev Bras Ortop       Date:  2015-11-16

9.  Is [F-18]-fluorodeoxy-D-glucose positron emission tomography of value in the management of patients with craniofacial bone sarcomas undergoing neo-adjuvant treatment?

Authors:  Anna Maria Frezza; Tim Beale; Jamshed Bomanji; Amrita Jay; Nicholas Kalavrezos; Palma Dileo; Jeremy Whelan; Sandra J Strauss
Journal:  BMC Cancer       Date:  2014-01-15       Impact factor: 4.430

10.  Optimization and In Vivo Profiling of a Refined Rat Model of Walker 256 Breast Cancer Cell-Induced Bone Pain Using Behavioral, Radiological, Histological, Immunohistochemical and Pharmacological Methods.

Authors:  Priyank Shenoy; Andy Kuo; Irina Vetter; Maree T Smith
Journal:  Front Pharmacol       Date:  2017-07-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.